Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
Manuel
M
Castro-Fernández
Diego
D
Sánchez-Muñoz
Elena
E
Ruíz-Granados
Nicolas
N
Merchante
Juan
J
Corzo
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000150:complications* / Q000188:drug therapy; D016463:Sweet Syndrome / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine